Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Austin

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
The Journal of Comparative Neurology|September 11, 2003
Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization studyPaul J Shughrue, Betty Ky, Christopher P Austin
The AAPS Journal|April 25, 2012
Paradigm shift in toxicity testing and modelingHongmao Sun, Menghang Xia, Christopher P Austin, et al.
The New England Journal of Medicine|October 12, 2017
Voluntary Site Accreditation - Improving the Execution of Multicenter Clinical TrialsS Claiborne Johnston, Christopher P Austin, Freda Lewis-Hall
Human Gene Therapy|January 20, 2016
Gene Therapy: The View from NCATSPhilip J Brooks, N Nora Yang, Christopher P Austin
Nature Reviews. Drug Discovery|May 28, 2021
Envisioning an actionable research agenda to facilitate repurposing of off-patent drugsChristopher P Austin, Bobbie Ann Mount, Christine M Colvis
Cancer Research|January 17, 2012
Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnershipScott J Weir, Louis J DeGennaro, Christopher P Austin
Advances in Experimental Medicine and Biology|December 8, 2017
A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC)Christine M Cutillo, Christopher P Austin, Stephen C Groft
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 17, 2008
Toxicity testing in the 21st century: implications for human health risk assessmentRobert J Kavlock, Christopher P Austin, Raymond R Tice
Clinical and Translational Science|November 10, 2018
Deconstructing the Translational Tower of BabelChristopher P Austin, Christine M Colvis, Noel T Southall
Human Molecular Genetics|June 19, 2003
DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutationJill A Morris, Geeta Kandpal, Lei Ma, et al.
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
The Journal of Comparative Neurology|September 11, 2003
Localization of B1 bradykinin receptor mRNA in the primate brain and spinal cord: an in situ hybridization studyPaul J Shughrue, Betty Ky, Christopher P Austin
The AAPS Journal|April 25, 2012
Paradigm shift in toxicity testing and modelingHongmao Sun, Menghang Xia, Christopher P Austin, et al.
The New England Journal of Medicine|October 12, 2017
Voluntary Site Accreditation - Improving the Execution of Multicenter Clinical TrialsS Claiborne Johnston, Christopher P Austin, Freda Lewis-Hall
Human Gene Therapy|January 20, 2016
Gene Therapy: The View from NCATSPhilip J Brooks, N Nora Yang, Christopher P Austin
Nature Reviews. Drug Discovery|May 28, 2021
Envisioning an actionable research agenda to facilitate repurposing of off-patent drugsChristopher P Austin, Bobbie Ann Mount, Christine M Colvis
Cancer Research|January 17, 2012
Repurposing approved and abandoned drugs for the treatment and prevention of cancer through public-private partnershipScott J Weir, Louis J DeGennaro, Christopher P Austin
Advances in Experimental Medicine and Biology|December 8, 2017
A Global Approach to Rare Diseases Research and Orphan Products Development: The International Rare Diseases Research Consortium (IRDiRC)Christine M Cutillo, Christopher P Austin, Stephen C Groft
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 17, 2008
Toxicity testing in the 21st century: implications for human health risk assessmentRobert J Kavlock, Christopher P Austin, Raymond R Tice
Clinical and Translational Science|November 10, 2018
Deconstructing the Translational Tower of BabelChristopher P Austin, Christine M Colvis, Noel T Southall
Human Molecular Genetics|June 19, 2003
DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutationJill A Morris, Geeta Kandpal, Lei Ma, et al.
Pageof 22